Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-27 13:03:30 - browse：1

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： EU fines Illumina $475 million over Grail acquisition

entertainment

WSS

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Grail's uphill battle for Medicare to cover its cancer screening test

Britney Spears to release memoir, 'The Woman In Me,' later this year

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Supreme Court rules employers must be more accommodating of religious observance

Synthetic human embryos? Researchers say term is overblown

focus

Wikipedia

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

Grail's uphill battle for Medicare to cover its cancer screening test

At least 13 dead in Texas as scorching temps continue

ADA: All diabetes patients should be screened for liver condition

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ukrainian soldiers say they owe lives to US

Apple is now the first public company to be valued at $3 trillion

Brazil's Jair Bolsonaro is barred from running for office until 2030

Hollywood unions extend contract negotiations for actors

UnitedHealth wins $3.3 billion takeover of Amedisys

focus

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Companies helping big Covid

Blinken talks high

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

The simple reason for the increase in autism diagnosis

entertainment

hotspot

Wikipedia

hotspot